A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION

Clinical trial NCT04262375 · WITHDRAWN

Trial details

NCT number: NCT04262375
Sponsor: University Health Network, Toronto
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Renal Cell Carcinoma

Start date: 2021-01-01
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.